Artwork

Content provided by UC Science Today and University of California. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UC Science Today and University of California or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Could the progression of glaucoma be halted?

1:03
 
Share
 

Manage episode 195454424 series 79752
Content provided by UC Science Today and University of California. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UC Science Today and University of California or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Glaucoma is the world’s second-leading cause of blindness, and it affects about 80 million people worldwide and has no cure. But vision scientists at the University of California, Berkeley, have discovered molecules that could probably halt the progression of the disease. Gronert: “We identified a novel factor, a new factor that potentially protects the optic nerve against damage, which is one of the underlying causes of glaucoma. That’s Karsten Gronert, a professor of optometry at UC Berkeley. He says, for decades, academic labs and pharmaceutical companies were trying to find treatment for glaucoma, but couldn’t show any promising results. This is probably because they were targeting the disease when it was already too late. "Once you have a degeneration of the optic nerve head, which is what causes glaucoma and eventually leads to blindness, that process is irreversible and cannot be stopped.” So Gronert and his colleagues took a different route. Instead of trying to fix what has been permanently damaged, they focused on prevention - protecting the mechanism that stops nerve degeneration.
  continue reading

147 episodes

Artwork
iconShare
 
Manage episode 195454424 series 79752
Content provided by UC Science Today and University of California. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UC Science Today and University of California or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Glaucoma is the world’s second-leading cause of blindness, and it affects about 80 million people worldwide and has no cure. But vision scientists at the University of California, Berkeley, have discovered molecules that could probably halt the progression of the disease. Gronert: “We identified a novel factor, a new factor that potentially protects the optic nerve against damage, which is one of the underlying causes of glaucoma. That’s Karsten Gronert, a professor of optometry at UC Berkeley. He says, for decades, academic labs and pharmaceutical companies were trying to find treatment for glaucoma, but couldn’t show any promising results. This is probably because they were targeting the disease when it was already too late. "Once you have a degeneration of the optic nerve head, which is what causes glaucoma and eventually leads to blindness, that process is irreversible and cannot be stopped.” So Gronert and his colleagues took a different route. Instead of trying to fix what has been permanently damaged, they focused on prevention - protecting the mechanism that stops nerve degeneration.
  continue reading

147 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide